JS
Therapeutic Areas
Authera Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AuT-1 | Exudative eye diseases (e.g., wet AMD, diabetic macular edema) | Pre-clinical |
| Undisclosed Pipeline | Not Specified (FcRn biology-based) | Pre-clinical |
| Undisclosed | Not Specified | Pre-clinical |
Leadership Team at Authera
SM
Simone Mester
CEO & Co-founder
TT
Torleif T. Gjølberg
CSO & Co-founder
HP
Hans Petter Tjeldflaat
CFO
GC
Gaia Calamera
Lead Senior Scientist
MA
Milena A. Blaga
Senior Scientist
JT
Jan Terje Andersen
Chairman of the Board & Co-founder
IS
Inger Sandlie
Board Member & Co-founder
ES
Eirik Sundlisæter
Medical Advisor
SM
Simone Mester
CEO & Co-founder
TT
Torleif T. Gjølberg
CSO & Co-founder